Out of the 220 SGX-Catalist stocks, we had to pick a stock to initiate a Buy call on. After conducting various screenings and understanding the story of various Catalist counters, Hyphens Pharma stood …
Hyphens Pharma (1J5): Undervalued Proxy to ASEAN Pharmaceuticals | Current: S$0.20 | Target: S$0.29 | Upside: +45% |
Hyphens Pharma (1J5): Undervalued Proxy to ASEAN Pharmaceuticals | Current: S$0.20 | Target: S$0.29 | Upside: +45% |
Leave a reply